Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis

Gabriel C. Barsotti, Randy Luciano, Ashwani Kumar, Kristin Meliambro, Vijayakumar Kakade, Joji Tokita, Abhijit Naik, Jia Fu, Elizabeth Peck, John Pell, Anand Reghuvaran, E.M. Tanvir, Prashant Patel, Weijia Zhang, Fan Li, Gilbert Moeckel, Sudhir Perincheri, Lloyd Cantley, Dennis G. Moledina, F. Perry Wilson, John C. He, Madhav C. Menon

Open source

DOI: 10.1016/j.ekir.2024.02.006
Published: 2024-05
Container: Kidney International Reports
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2024.02.006,
  title = {Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis},
  author = {Gabriel C. Barsotti and Randy Luciano and Ashwani Kumar and Kristin Meliambro and Vijayakumar Kakade and Joji Tokita and Abhijit Naik and Jia Fu and Elizabeth Peck and John Pell and Anand Reghuvaran and E.M. Tanvir and Prashant Patel and Weijia Zhang and Fan Li and Gilbert Moeckel and Sudhir Perincheri and Lloyd Cantley and Dennis G. Moledina and F. Perry Wilson and John C. He and Madhav C. Menon},
  year = {2024},
  journal = {Kidney International Reports},
  doi = {10.1016/j.ekir.2024.02.006},
  url = {https://doi.org/10.1016/j.ekir.2024.02.006}
}

RIS

TY  - JOUR
TI  - Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis
AU  - Gabriel C. Barsotti
AU  - Randy Luciano
AU  - Ashwani Kumar
AU  - Kristin Meliambro
AU  - Vijayakumar Kakade
AU  - Joji Tokita
AU  - Abhijit Naik
AU  - Jia Fu
AU  - Elizabeth Peck
AU  - John Pell
AU  - Anand Reghuvaran
AU  - E.M. Tanvir
AU  - Prashant Patel
AU  - Weijia Zhang
AU  - Fan Li
AU  - Gilbert Moeckel
AU  - Sudhir Perincheri
AU  - Lloyd Cantley
AU  - Dennis G. Moledina
AU  - F. Perry Wilson
AU  - John C. He
AU  - Madhav C. Menon
PY  - 2024
JO  - Kidney International Reports
DO  - 10.1016/j.ekir.2024.02.006
UR  - https://doi.org/10.1016/j.ekir.2024.02.006
ER  -

APA

Barsotti, G. C., Luciano, R., Kumar, A., Meliambro, K., Kakade, V., Tokita, J., Naik, A., Fu, J., Peck, E., Pell, J., Reghuvaran, A., Tanvir, E., Patel, P., Zhang, W., Li, F., Moeckel, G., Perincheri, S., Cantley, L., Moledina, D. G., Wilson, F. P., He, J. C., & Menon, M. C. (2024). Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis. Kidney International Reports. https://doi.org/10.1016/j.ekir.2024.02.006

Source records

crossref · retrieved 2026-09-26T15:40:21.011Z